Richard R. Kerr

Kerr is group content director for Urology Times.


Bladder Cancer: Androgen receptor activation a potential therapeutic target

July 19, 2016

Multiple studies on exosomes, data from the IMvigor 210 trial of atezolizumab (TECENTRIQ), and research on prehabilitation for cystectomy were among the highlights in bladder cancer from the 2016 AUA annual meeting.

Best of AUA 2015: PCa surveillance, surgical controversies create buzz

July 01, 2015

Urology Times’ “Best of AUA 2015” report provides a guide to the meeting’s take-home messages in 15 therapeutic areas-an information-packed, condensed summary of the top papers and presentations.

Novel agent may protect against major UTI pathogen

May 04, 2015

An experimental drug that stabilizes a protein protects human bladder cells against a major UTI pathogen, researchers say.